BLC
TMO icon

Brown, Lisle/Cummings’s Thermo Fisher Scientific TMO Stock Holding History

Brown, Lisle/Cummings’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.4M Buy
8,953
+372
+4% +$202K 1.1% 22
2025
Q4 		$4.97M Buy
8,581
+1,775
+26% +$1M 1.23% 18
2025
Q3 		$3.3M Sell
6,806
-200
-3% -$93.1K 0.85% 30
2025
Q2 		$2.84M Buy
7,006
+340
+5% +$142K 0.76% 36
2025
Q1 		$3.32M Sell
6,666
-2
-0% -$1.08K 0.96% 25
2024
Q4 		$3.47M Sell
6,668
-59
-0.9% -$32.4K 1.04% 23
2024
Q3 		$4.16M Buy
6,727
+300
+5% +$178K 1.26% 17
2024
Q2 		$3.55M Buy
6,427
+15
+0.2% +$8.59K 1.16% 21
2024
Q1 		$3.73M Buy
6,412
+360
+6% +$202K 1.27% 21
2023
Q4 		$3.21M Buy
6,052
+175
+3% +$84.7K 1.19% 21
2023
Q3 		$2.97M Buy
5,877
+144
+3% +$76.7K 1.35% 20
2023
Q2 		$2.99M Buy
5,733
+235
+4% +$127K 1.34% 18
2023
Q1 		$3.17M Sell
5,498
-50
-0.9% -$28.2K 1.61% 13
2022
Q4 		$3.06M Buy
5,548
+261
+5% +$138K 1.64% 12
2022
Q3 		$2.68M Sell
5,287
-35
-0.7% -$19.6K 1.57% 14
2022
Q2 		$2.89M Sell
5,322
-140
-3% -$77.1K 1.6% 14
2022
Q1 		$3.23M Buy
5,462
+130
+2% +$74.7K 1.55% 14
2021
Q4 		$3.56M Buy
+5,332
New +$3.33M 1.78% 12

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Brown, Lisle/Cummings's TMO Position: Q1 2026 in Review

Brown, Lisle/Cummings increased its Thermo Fisher Scientific (TMO) stake by 4.3% in Q1 2026, buying an estimated $202K and bringing the position to 8,953 shares worth $4.4M. The position accounts for 1.1% of the portfolio, ranked #22.

Brown, Lisle/Cummings first reported a position in TMO in Q4 2021 and has held it in 18 quarters since. The position peaked at $4.97M in Q4 2025. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Brown, Lisle/Cummings held 8,953 shares of Thermo Fisher Scientific worth $4.4M as of Q1 2026.
  • Brown, Lisle/Cummings bought 372 Thermo Fisher Scientific shares in Q1 2026, an estimated $202K.
  • Thermo Fisher Scientific made up 1.1% of Brown, Lisle/Cummings's portfolio in Q1 2026, its #22 holding.
  • Brown, Lisle/Cummings first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 18 quarters since.
  • Brown, Lisle/Cummings's Thermo Fisher Scientific position peaked at $4.97M in Q4 2025.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Brown, Lisle/Cummings's 13F filing for Q1 2026, filed 20 Apr 2026.